We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
35 hedge funds and large institutions have $6.05M invested in CASI Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
17% more funds holding
Funds holding: 30 → 35 (+5)
7% more capital invested
Capital invested by funds: $5.66M → $6.05M (+$385K)
Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
+$94.6K |
| 2 |
WJA
Williams Jones & Associates
New York
|
+$80.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.8K |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$28.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$24.2K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$425K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$8.97K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
